[1]
Que, Y.A.; Moreillon, P. Infective endocarditis. Nat. Rev. Cardiol., 2011, 8, 322-336.
[2]
Fitzsimmons, K.; Bamber, A.I.; Smalley, H.B. Infective endocarditis: Changing aetiology of disease. Br. J. Biomed. Sci., 2010, 67, 35-41.
[3]
Haldar, S.M.; O’Gara, P.T. Infective endocarditis: Diagnosis and management. Nat. Clin. Pract. Cardiovasc. Med., 2006, 3, 310-317.
[4]
Durack, D.T. Infective endocarditis. Infect. Dis. Clin. North Am., 2002, 16, xv-xix.
[5]
Morpeth, S.; Murdoch, D.; Cabell, C.H.; Karchmer, A.W.; Pappas, P.; Levine, D.; Nacinovich, F.; Tattevin, P.; Fernández-Hidalgo, N.; Dickerman, S.; Bouza, E.; del Río, A.; Lejko-Zupanc, T.; de Oliveira Ramos, A.; Iarussi, D.; Klein, J.; Chirouze, C.; Bedimo, R.; Corey, G.R.; Fowler, V.G. Jr; International Collaboration on Endocarditis Prospective Cohort Study (ICE-PCS) Investigators. Non-HACEK Gram-negative bacillus endocarditis. Ann. Intern. Med., 2007, 147, 829-835.
[7]
McDonald, J.R. Acute infective endocarditis. Infect. Dis. Clin. North Am., 2009, 23, 643-664.
[8]
Mocchegiani, R.; Nataloni, M. Complications of infective endocarditis. Cardiovasc. Hematol. Disord. Drug Targets, 2009, 9, 240-248.
[9]
Derex, L.; Bonnefoy, E.; Delahaye, F. Impact of stroke on therapeutic decision making in infective endocarditis. J. Neurol., 2010, 257, 315-321.
[10]
Heiro, M.; Nikoskelainen, J.; Engblom, E.; Kotilainen, E.; Marttila, R.; Kotilainen, P. Neurologic manifestations of infective endocarditis: A 17-year experience in a teaching hospital in Finland. Arch. Intern. Med., 2000, 160, 2781-2787.
[11]
Kanter, M.C.; Hart, R.G. Neurologic complications of infective endocarditis. Neurology, 1991, 41, 1015-1020.
[12]
Moreillon, P.; Que, Y.A. Infective endocarditis. Lancet, 2004, 363, 139-149.
[13]
Cabell, C.H.; Fowler, V.G. Jr, Engemann, J.J. Endocarditis in the elderly: Incidence, surgery, and survival in 16,921 patients over 12 years. Circulation, 2002, 106, 547.
[14]
Reyes, M.P.; Ali, A.; Mendes, R.E.; Biedenbach, D.J. Resurgence of Pseudomonas endocarditis in Detroit, 2006-2008. Medicine (Baltimore), 2009, 88, 294-301.
[15]
Noureddine, M.; de la Torre, J.; Ivanova, R.; Martínez, F.J.; Lomas, J.M.; Plata, A.; Gálvez, J.; Reguera, J.M.; Ruiz, J.; Hidalgo, C.; Luque, R.; García-López, M.V.; de Alarcón, A. Left-sided endocarditis due to gram-negative bacilli: Epidemiology and clinical characteristics. Enferm. Infecc. Microbiol. Clin., 2011, 29(4), 276-281.
[16]
Nasim, A.; Baqi, S.; Akhtar, S.F. Pseudomonas aeruginosa endocarditis in renal transplant recipients. Transpl. Infect. Dis., 2012, 14(2), 180-183.
[17]
Aggarwal, A.; Ritter, N.; Reddy, L.; Lingutla, D.; Nasar, F.; El-Daher, N.; His, D. Recurrent Pseudomonas aortic root abscess complicating mitral valve endocarditis. Heart Lung, 2012, 41(2), 181-183.
[18]
Wei, H.H.; Wu, K.G.; Sy, L.B.; Chen, C.J.; Tang, R.B. Infectious endocarditis in pediatric patients: analysis of 19 cases presenting at a medical center. J. Microbiol. Immunol. Infect., 2010, 43, 430-437.
[19]
Tembe, A.G.; Kharbanda, P.; Dalal, J.J.; Vaishnav, G.; Joshi, V.R. Infective endocarditis--a tale of two cases and the lessons (re)learned. J. Assoc. Physicians India, 2010, 58, 319-322.
[20]
Bicanic, T.A.; Eykyn, S.J. Hospital-acquired, native valve endocarditis caused by Pseudomonas aeruginosa. J. Infect., 2002, 44, 137-139.
[21]
Wieland, M.; Lederman, M.M.; Kline-King, C.; Keys, T.F.; Lerner, P.I.; Bass, S.N.; Chmielewski, R.; Banks, V.D.; Ellner, J.J. Left-sided endocarditis due to Pseudomonas aeruginosa: A report of 10 cases and review of the literature. Medicine, 1986, 65, 180-189.
[22]
Reyes, M.P.; Lerner, A.M. Current problems in the treatment of infective endocarditis due to Pseudomonas aeruginosa. Rev. Infect. Dis., 1983, 5, 314-321.
[23]
Parlakay, A.O.; Kara, A.; Çelik, I.; Cengiz, A.B.; Karagöz, T.; Devrim, I.; Ceyhan, M. Winning the battle against Pseudomonas aeruginosa endocarditis: A case report. Çocuk Enfeks. Derg., 2010, 4, 114-116.
[24]
Kato, Y.; Ohashi, H.; Tsutsumi, Y.; Murakami, T.; Takahashi, Y. Prosthetic valve endocarditis caused by metallo-beta-lactamase-producing Pseudomonas aeruginosa. J. Card. Surg., 2009, 24, 347-349. Reyes MP, Ali A, Mendes RE, Biedenbach DJ. Resurgence of Pseudomonas endocarditis in Detroit, 2006-2008. Medicine (Baltimore), 2009, 88(5), 294-301.
[25]
Thompson, J.; Meddens, M.J.; Thörig, L.; van Furth, R. The role of bacterial adherence in the pathogenesis of infective endocarditis. Infection, 1982, 10, 196-198.
[26]
Ho, M.H.; Guo, Z.M.; Chunga, J.; Goodwin, J.S.; Xie, H. Characterization of innate immune responses of human endothelial cells induced by Porphyromonas gingivalis and their derived outer membrane vesicles. Front. Cell. Infect. Microbiol., 2016, 6, 139.
[27]
Deshpande, R.G.; Khan, M.B.; Genco, C.A. Invasion of aortic and heart endothelial cells by Porphyromonas gingivalis. Infect. Immun., 1998, 66(11), 5337-5343.
[28]
Chou, H.H.; Yumoto, H.; Davey, M.; Takahashi, Y.; Miyamoto, T.; Gibson, F.C. 3rd, Genco, C.A. Porphyromonas gingivalis fimbria-dependent activation of inflammatory genes in human aortic endothelial cells. Infect. Immun., 2005, 73(9), 5367-5378.
[29]
Khlgatian, M.; Nassar, H.; Chou, H.H.; Gibson, F.C. 3rd, Genco, C.A. Fimbria-dependent activation of cell adhesion molecule expression in Porphyromonas gingivalis-infected endothelial cells. Infect. Immun., 2002, 70(1), 257-267.
[30]
Komatsu, T.; Nagano, K.; Sugiura, S.; Hagiwara, M.; Tanigawa, N.; Abiko, Y.; Yoshimura, F.; Furuichi, Y.; Matsushita, K. E-selectin mediates Porphyromonas gingivalis adherence to human endothelial cells. Infect. Immun., 2012, 80(7), 2570-2576.
[31]
Vielma, S.A.; Krings, G.; Lopes-Virella, M.F. Chlamydophila pneumoniae induces ICAM-1 expression in human aortic endothelial cells via protein kinase C-dependent activation of nuclear factor-kappaB. Circ. Res., 2003, 92(10), 1130-1137.
[32]
Mueller, K.E.; Wolf, K. C. pneumoniae disrupts eNOS trafficking and impairs NO production in human aortic endothelial cells. Cell. Microbiol., 2015, 17(1), 119-130.
[33]
Herrera, A.; Kulhankova, K.; Sonkar, V.K.; Dayal, S.; Klingelhutz, A.J.; Salgado-Pabon, W.; Schlievert, P.M. Staphylococcal beta-toxin modulates human aortic endothelial cell and platelet function through sphingomyelinase and biofilm ligase activities. MBio, 2017, 8(2), e00273-e17.
[34]
Nagata, E.; de Toledo, A.; Oho, T. Invasion of human aortic endothelial cells by oral viridans group streptococci and induction of inflammatory cytokine production. Mol. Oral Microbiol., 2011, 26(1), 78-88.
[35]
de Toledo, A.; Nagata, E.; Yoshida, Y.; Oho, T. Streptococcus oralis coaggregation receptor polysaccharides induce inflammatory responses in human aortic endothelial cells. Mol. Oral Microbiol., 2012, 27(4), 295-307.
[36]
di Penta, A.; Moreno, B.; Reix, S.; Fernandez-Diez, B.; Villanueva, M.; Errea, O.; Escala, N.; Vandenbroeck, K.; Comella, J.X.; Villoslada, P. Oxidative stress and proinflammatory cytokines contribute to demyelination and axonal damage in a cerebellar culture model of neuroinflammation. PLoS One, 2013, 8(2), e54722.
[37]
Araújo, I.R.; Ferrari, T.C.; Teixeira-Carvalho, A.; Campi-Azevedo, A.C.; Rodrigues, L.V.; Guimarães Júnior, M.H.; Barros, T.L.; Gelape, C.L.; Sousa, G.R.; Nunes, M.C. Cytokine signature in infective endocarditis. PLoS One, 2015, 10(7), e0133631.
[38]
Nunes, M.C.P. AI, Carvalho, A.T.; Andrade, L.A.; Resende, M.H.L.; Silva, J.L.P.; Ferrari, T.C.A. Do cytokines play a role in predicting some features and outcome in infective endocarditis? Adv. Infect. Dis., 2013, 3, 115-119.
[39]
Chu, C.Q. How much have we learnt about the TNF family of cytokines? Cytokine, 2018, 101, 1-3.
[40]
Zelová, H.; Hošek, J. TNF-α signalling and inflammation: Interactions between old acquaintances. Inflamm. Res., 2013, 62(7), 641-651.
[41]
Moorlag, S.J.C.F.M.; Röring, R.J.; Joosten, L.A.B.; Netea, M.G. The role of the interleukin-1 family in trained immunity. Immunol. Rev., 2018, 281(1), 28-39.
[42]
Dinarello, C.A. Introduction to the interleukin-1 family of cytokines and receptors: Drivers of innate inflammation and acquired immunity. Immunol. Rev., 2018, 281(1), 5-7.
[43]
Striz, I. Cytokines of the IL-1 family: Recognized targets in chronic
inflammation underrated in organ transplantations. Clin. Sci.,
(Lond). 2017, 131(17), 2241-2256.
[44]
Ridker, P.M.N.; Rafai, M.J.; Stampfer, C.H. Hennekens. 2000. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation, 2000, 101, 1767-1772.
[45]
Tanaka, T.; Kanda, T.; McManus, B.M.; Kanai, H.; Akiyama, H.; Sekiguchi, K.; Yokoyama, T.; Kurabayashi, M. Overexpression of interleukin-6 aggravates viral myocarditis: impaired increase in tumor necrosis factor-α. J. Mol. Cell. Cardiol., 2001, 33, 1627-1635.
[46]
Bickel, M. The role of interleukin-8 in inflammation and mechanisms of regulation. J. Periodontol., 1993, 64(5)(Suppl.), 456-460.
[47]
Shah, R.; Thomas, R.; Mehta, D.S. Neutrophil priming: Implications in periodontal disease. J. Indian Soc. Periodontol., 2017, 21(3), 180-185.
[48]
Laursen, H.; Jensen, H.E.; Leifsson, P.S.; Jensen, L.K.; Christiansen, J.G.; Trebbien, R.; Nielsen, O.L. Immunohistochemical detection of interleukin-8 in inflamed porcine tissues. Vet. Immunol. Immunopathol., 2014, 159(1-2), 97-102.
[49]
Baggiolini, M.; Clark-Lewis, I. Interleukin-8, a chemotactic and inflammatory cytokine. FEBS Lett., 1992, 307(1), 97-101.
[50]
Watkin, R.W.; Harper, L.V.; Vernallis, A.B.; Lang, S.; Lambert, P.A.; Ranasinghe, A.M.; Elliott, T.S. Pro-inflammatory cytokines IL6, TNF-alpha, IL1beta, procalcitonin, lipopolysaccharide binding protein and C-reactive protein in infective endocarditis. J. Infect., 2007, 55, 220-225.
[51]
Rawczynska-Englert, I.; Hryniewiecki, T.; Dzierzanowska, D. Evaluation of serum cytokine concentrations in patients with infective endocarditis. J. Heart Valve, 2000, 9, 705-709.
[52]
Gouriet, F.; Bothelo-Nevers, E.; Coulibaly, B.; Raoult, D.; Casalta, J.P. Evaluation of sedimentation rate, rheumatoid factor, C-reactive protein, and tumor necrosis factor for the diagnosis of infective endocarditis. Clin. Vaccine Immunol., 2006, 13, 301.
[53]
Zeng, C.; Hu, X.; Wang, Y.; Zeng, X.; Xiong, Y.; Li, L.; Ye, Q. A novel hypothermic machine perfusion system using a LifePort Kidney Transporter for the preservation of rat liver. Exp. Ther. Med., 2018, 15(2), 1410-1416.
[54]
Zhao, P.; Chang, R.Y.; Liu, N.; Wang, J.; Zhou, R.; Qi, X.; Liu, Y.; Ma, L.; Niu, Y.; Sun, T.; Li, Y.X.; He, Y.P.; Yu, J.Q. Neuroprotective effect of oxysophocarpine by modulation of mapk pathway in rat hippocampal neurons subject to oxygen-glucose deprivation and reperfusion. Cell. Mol. Neurobiol., 2018, 38(2), 29-540.
[55]
Roth, G.A.; Ankersmit, H.J.; Brown, V.B.; Papapanou, P.N.; Schmidt, A.M.; Lalla, E. Porphyromonas gingivalis infection and cell death in human aortic endothelial cells. FEMS Microbiol. Lett., 2007, 272(1), 106-113.
[56]
Marino, J.; Stoeckli, I.; Walch, M.; Latinovic-Golic, S.; Sundstroem, H.; Groscurth, P.; Ziegler, U.; Dumrese, C. Chlamydophila pneumoniae derived from inclusions late in the infectious cycle induce aponecrosis in human aortic endothelial cells. BMC Microbiol., 2008, 8, 32.
